Literature DB >> 31273865

Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data.

Luigi Menghini1, Lucia Recinella1, Sheila Leone1, Annalisa Chiavaroli1, Carla Cicala2, Luigi Brunetti1, Sanda Vladimir-Knežević3, Giustino Orlando1, Claudio Ferrante1.   

Abstract

Devil's Claw is a traditional medicine that has been long used a wide range of health conditions, including indigestion, fever, allergic reactions, and rheumatism. The main compounds are iridoid glycosides, including harpagoside, harpagide, and procumbide. However, harpagoside is the most responsible for therapeutic activity, and its content is used as reference standard. Here, we analyzed and summarized preclinical and clinical studies focusing on therapeutic efficacy of devil's claw preparations in pathological conditions in which inflammation plays a key causative role.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  arthritis; atherosclerosis; inflammatory bowel disease; neurodegenerative diseases; osteoporosis; type 1 diabetes

Mesh:

Year:  2019        PMID: 31273865     DOI: 10.1002/ptr.6395

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

Review 1.  The Fight against Infection and Pain: Devil's Claw (Harpagophytum procumbens) a Rich Source of Anti-Inflammatory Activity: 2011-2022.

Authors:  Nomagugu Gxaba; Madira Coutlyne Manganyi
Journal:  Molecules       Date:  2022-06-06       Impact factor: 4.927

2.  Leucosceptoside A from Devil's Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes.

Authors:  Ivanka K Koycheva; Liliya V Mihaylova; Monika N Todorova; Zhivka P Balcheva-Sivenova; Kalina Alipieva; Claudio Ferrante; Giustino Orlando; Milen I Georgiev
Journal:  Molecules       Date:  2021-11-20       Impact factor: 4.411

3.  Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy.

Authors:  Weili Li; Xiaoping Wang; Tianhua Liu; Qian Zhang; Jing Cao; Yanyan Jiang; Qianbin Sun; Chun Li; Wei Wang; Yong Wang
Journal:  Front Cell Dev Biol       Date:  2022-02-10

4.  Analysis of Effectiveness of a Supplement Combining Harpagophytum procumbens, Zingiber officinale and Bixa orellana in Healthy Recreational Runners with Self-Reported Knee Pain: A Pilot, Randomized, Triple-Blind, Placebo-Controlled Trial.

Authors:  Marcela González-Gross; Carlos Quesada-González; Javier Rueda; Manuel Sillero-Quintana; Nicolas Issaly; Angel Enrique Díaz; Eva Gesteiro; David Escobar-Toledo; Rafael Torres-Peralta; Marc Roller; Amelia Guadalupe-Grau
Journal:  Int J Environ Res Public Health       Date:  2021-05-22       Impact factor: 3.390

5.  Phytochemical Analysis and Anti-Inflammatory and Anti-Osteoarthritic Bioactive Potential of Verbascum thapsus L. (Scrophulariaceae) Leaf Extract Evaluated in Two In Vitro Models of Inflammation and Osteoarthritis.

Authors:  Giovanna Calabrese; Agata Zappalà; Anna Dolcimascolo; Rosaria Acquaviva; Rosalba Parenti; Giuseppe Antonio Malfa
Journal:  Molecules       Date:  2021-09-05       Impact factor: 4.411

Review 6.  Herb-Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements.

Authors:  Annemarie Lippert; Bertold Renner
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.